Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
Quick Stats
Feb 02, 202650.2
AI Score
HOLD0.59
Volume Ratio
Mar 02, 2026
Next Earnings
11
+ve Days (30d)
17
-ve Days (30d)
SAVA Stock Summary
Last updated Feb 02, 2026
SAVA is currently trading at $1.94, positioned below its 200-day moving average of $2.46, suggesting bearish momentum. The stock has a 52-week range of $1.15 to $4.98.
Technical Analysis: The 50-day moving average stands at $2.5, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 37.847, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.006, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SAVA at 50.2/100 with a HOLD recommendation.
SAVA (Cassava Sciences, Inc.) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 37.847 |
| CMF (20) | -0.006 |
| ROC (10) | -4.902 |
| ADX (14) | 28.96 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.122 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -88.764 |
| MFI (14) | 34.554 |
SAVA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SAVA Price vs Max Options Open Interest
SAVA Max Change In Options Open Interest
SAVA Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SAVA Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SAVA Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SAVA Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Cassava Sciences, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
SAVA Moving Averages Analysis
SAVA (Cassava Sciences, Inc.) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 2.08 |
| 20 | 2.1 |
| 30 | 2.14 |
| 50 | 2.5 |
| 100 | 2.87 |
| 200 | 2.46 |
SAVA Fundamental Analysis
| P/E (Forward) | 151.5152 |
| P/E (Trailing) | -- |
| Market Cap ($) | 142.0 million |
| Earnings/Share ($) | -2.22 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.93 |
| EPS Estimate Next Year ($) | -1.22 |
| WallStreet Target Price ($) | 8 |
| Most Recent Quarter |
News Summary: Investors in $SAVA are expressing skepticism about the company's future, with some calling it a scam stock. The CEO's actions, including buying back shares, are being questioned. Despite the negative sentiment, some believe the company may pivot successfully from Alzheimer's to epilepsy research. The stock's history under previous leadership is also being cited as a reason for optimism.
Updated 2025-09-23 23:00:02